#01
Endocrine & Metabolic Research
CJCIPAM-5MG
Research compound
The certificate is public.
CJC-1295 (No DAC) + Ipamorelin is a two-peptide research formulation supplying 5 mg of Modified GRF (1-29) and 5 mg of Ipamorelin in a single lyophilized vial. CJC-1295 (No DAC) is a 29-amino-acid GHRH analogue with four substitutions that resist DPP-IV cleavage; Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) that acts selectively at the growth hormone secretagogue receptor. Each vial is manufactured to ≥99% purity, verified by HPLC and mass spectrometry, and supplied for use in qualified laboratory and research settings investigating growth-hormone-axis signalling. Key Features * 5 mg CJC-1295 (No DAC) + 5 mg Ipamorelin per vial * 10 mg total lyophilized powder * ≥99% purity by HPLC * Identity confirmed by mass spectrometry * DPP-IV-resistant GHRH analogue * Selective GHSR agonist with minimal cortisol/prolactin activity in research models * Lot-specific certificate of analysis * Research use only
Available · 1 size
UPS Next Day Air — standard on every order
01Research context
CJC-1295 (No DAC) and Ipamorelin act on two different receptors of the same endocrine axis and are commonly combined in preclinical research because their effects on pituitary somatotrophs are complementary. CJC-1295 (No DAC) binds the GHRH receptor and raises the amplitude of growth-hormone pulses; lacking the Drug Affinity Complex, it does not bind serum albumin, so it has a short half-life and preserves the natural pulsatile release pattern rather than producing sustained elevation. Ipamorelin initiates a growth-hormone pulse through the ghrelin receptor and, relative to earlier secretagogues such as GHRP-2 and GHRP-6, shows minimal stimulation of cortisol, prolactin, or ACTH in research models. Because the two pathways converge on somatotroph cAMP and calcium signalling, co-administration in animal models produces a greater GH response than either peptide alone, making the pair a standard tool for pulse-amplitude, pulse-frequency, IGF-1 axis, and comparative secretagogue-selectivity studies. Intended Use For laboratory research use only. Intended for reconstitution by qualified personnel using an appropriate sterile diluent in controlled research settings. Handling Notes Store lyophilized vials refrigerated at 2–8 °C short term or frozen at −20 °C for extended storage, protected from light. Allow the vial to reach room temperature before opening. Reconstitute with bacteriostatic water, adding diluent slowly down the vial wall without shaking; refrigerate after reconstitution and use within 30 days. Account for both peptide concentrations in experimental design. Warnings Research use only. Not for human or veterinary use. Not for drug, food, cosmetic, household, or diagnostic use. Not intended to diagnose, treat, cure, or prevent any disease. Neither component is FDA approved. Keep out of reach of children.
02Storage & handling
Lyophilized
Store sealed vials at −20 °C, protected from light.
Reconstituted
Refrigerate at 2–8 °C and use within the period stated on the COA.
Handling
Allow vials to reach room temperature before opening to avoid condensation.
Same research area
IMPORTANT:All products sold on this website are intended strictly for in-vitro research and laboratory use only. These products are NOT for human or animal consumption, therapeutic use, or any form of in-vivo application. Apex Peptides does not condone or promote any use outside of legitimate scientific research. Purchasers must be qualified researchers or institutions and assume all responsibility for compliance with applicable laws and regulations.
Documentation
Every lot ships with a published certificate of analysis.
Research use only
This product is intended strictly for in-vitro research and laboratory use. Not for human or animal consumption, therapeutic use, or any form of in-vivo application.
